InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,677.20
(
0.18%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.08
(
-0.29%
)
Bitcoin
55,225.39
(
-3.08%
)
Post# of 252487
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Titan V

Send PM Follow Ignore
Followers 31
Posts 3757
Boards Moderated 0
Alias Born 01/29/2012

Titan V

Re: Titan V post# 217703

Tuesday, 03/06/2018 10:09:08 AM

Tuesday, March 06, 2018 10:09:08 AM

Post# of 252487
MRNS delays p2 PPD readout for IV Ganaxolone to Q3’18, increases enrollment. This is the second delay (originally scheduled for Dec ‘17, then pushed to early ‘18). Oral Ganax PPD trial readout in Q4’18.

Is Ganax a dud? Maybe. But to be fair SAGE-217 results were pushed 6 months to increase N too recently. SAGE-517 p2 results could have been an outlier as p3 wasn’t as good as p2. Anyway, I’m out of MRNS for now.

https://seekingalpha.com/pr/17092925-marinus-pharmaceuticals-provides-business-update-2017-financial-results
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up